Cargando…

Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya

BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Bruce A., Bii, Margaret, Halim, Nafisa, Rohr, Julia K., Sugut, William, Sawe, Fredrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086393/
https://www.ncbi.nlm.nih.gov/pubmed/30096177
http://dx.doi.org/10.1371/journal.pone.0200199
_version_ 1783346503025164288
author Larson, Bruce A.
Bii, Margaret
Halim, Nafisa
Rohr, Julia K.
Sugut, William
Sawe, Fredrick
author_facet Larson, Bruce A.
Bii, Margaret
Halim, Nafisa
Rohr, Julia K.
Sugut, William
Sawe, Fredrick
author_sort Larson, Bruce A.
collection PubMed
description BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiated on ART during pregnancy over the first one and two years on treatment. The study site was the District Hospital in Kericho, Kenya. METHODS: A micro-costing approach from the provider’s perspective, based on a retrospective review of patient medical records, was used to evaluate incremental costs of care (2012 USD). Cost per patient in two cohorts were evaluated: the MCH clinic group comprised of adult women who initiated ART at the site’s MCH clinic during pregnancy between 2008–2011; and for comparison, the ART clinic group comprised of adult, non-pregnant women who initiated ART at the site’s ART clinic during 2008–2011. The two groups were matched on age and baseline CD4 count at initiation. Retention at year one/two on ART was defined as having completed a clinic visit at 365/730 days on ART +/- 90 days. RESULTS: For patients defined as retained in care at year one, average incremental costs per patient were $234 for the MCH clinic group (median: 215; IQR: 186, 282) and $292 in the ART clinic group (median: 227; IQR: 178, 357). ARV and laboratory costs were less on average for the MCH clinic group compared to the ART clinic group (due to lower cost regimens and fewer tests), while personnel costs were higher for the MCH clinic group. CONCLUSIONS: The annual incremental cost per patient of providing ART were similar in the two clinic settings in 2012. With shifts in recommended ARV regimens and lab monitoring over time, annual costs of care (using 2016 USD unit costs) have remained relatively constant in nominal terms for the MCH clinic group but have fallen substantially for the ART clinic group (from nominal $292 in 2012 to nominal $227 in 2016).
format Online
Article
Text
id pubmed-6086393
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60863932018-08-28 Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya Larson, Bruce A. Bii, Margaret Halim, Nafisa Rohr, Julia K. Sugut, William Sawe, Fredrick PLoS One Research Article BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiated on ART during pregnancy over the first one and two years on treatment. The study site was the District Hospital in Kericho, Kenya. METHODS: A micro-costing approach from the provider’s perspective, based on a retrospective review of patient medical records, was used to evaluate incremental costs of care (2012 USD). Cost per patient in two cohorts were evaluated: the MCH clinic group comprised of adult women who initiated ART at the site’s MCH clinic during pregnancy between 2008–2011; and for comparison, the ART clinic group comprised of adult, non-pregnant women who initiated ART at the site’s ART clinic during 2008–2011. The two groups were matched on age and baseline CD4 count at initiation. Retention at year one/two on ART was defined as having completed a clinic visit at 365/730 days on ART +/- 90 days. RESULTS: For patients defined as retained in care at year one, average incremental costs per patient were $234 for the MCH clinic group (median: 215; IQR: 186, 282) and $292 in the ART clinic group (median: 227; IQR: 178, 357). ARV and laboratory costs were less on average for the MCH clinic group compared to the ART clinic group (due to lower cost regimens and fewer tests), while personnel costs were higher for the MCH clinic group. CONCLUSIONS: The annual incremental cost per patient of providing ART were similar in the two clinic settings in 2012. With shifts in recommended ARV regimens and lab monitoring over time, annual costs of care (using 2016 USD unit costs) have remained relatively constant in nominal terms for the MCH clinic group but have fallen substantially for the ART clinic group (from nominal $292 in 2012 to nominal $227 in 2016). Public Library of Science 2018-08-10 /pmc/articles/PMC6086393/ /pubmed/30096177 http://dx.doi.org/10.1371/journal.pone.0200199 Text en © 2018 Larson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Larson, Bruce A.
Bii, Margaret
Halim, Nafisa
Rohr, Julia K.
Sugut, William
Sawe, Fredrick
Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title_full Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title_fullStr Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title_full_unstemmed Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title_short Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
title_sort incremental treatment costs for hiv-infected women initiating antiretroviral therapy during pregnancy: a 24-month micro-costing cohort study for a maternal and child health clinic in kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086393/
https://www.ncbi.nlm.nih.gov/pubmed/30096177
http://dx.doi.org/10.1371/journal.pone.0200199
work_keys_str_mv AT larsonbrucea incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya
AT biimargaret incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya
AT halimnafisa incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya
AT rohrjuliak incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya
AT sugutwilliam incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya
AT sawefredrick incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya